Simcere Pharmaceutical Group Limited Stock
Stocks
2096
HK0000658531
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.09 HKD | +1.68% |
|
+5.41% | +1.00% |
| 07-09 | Simcere Pharma's Acute Ischemic Stroke Included in National Essential Medicines List | MT |
| 06-15 | Simcere Pharma Gets China Nod for Tumor Drug Trial | MT |
| Market Cap | 3.96B 31.05B 3.46B 3.2B 2.95B 5.6B 378B 5.69B 38.18B 14.99B 186B 14.87B 14.55B 640B | P/E 2026 * |
16x | P/E 2027 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 3.74B 29.32B 3.27B 3.02B 2.79B 5.29B 357B 5.38B 36.05B 14.16B 176B 14.04B 13.74B 604B | EV / Sales 2026 * |
2.54x | EV / Sales 2027 * | 2.33x |
| Free-Float |
32.48% | Yield 2026 * |
3.17% | Yield 2027 * | 4.16% |
| 1 day | +1.68% | ||
| 1 week | +5.41% | ||
| Current month | +22.74% | ||
| 1 month | +22.87% | ||
| 3 months | -12.01% | ||
| 6 months | -0.49% | ||
| Current year | +1.00% |
| 1 week | 11.34 |  | 12.38 |
| 1 month | 9.07 | | 12.38 |
| Current year | 9.07 | | 14.28 |
| 1 year | 9.07 | | 15.08 |
| 3 years | 4.94 | | 15.08 |
| 5 years | 4.94 | | 15.08 |
| 10 years | 4.94 | | 15.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yun Shu Zhou
CEO | Chief Executive Officer | 54 | 25/03/2026 |
Yushan Wan
DFI | Director of Finance/CFO | 55 | 19/11/2019 |
Goh Han
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CHM | Chairman | 63 | 08/10/2012 |
Yushan Wan
BRD | Director/Board Member | 55 | 19/11/2019 |
Ren Hong Tang
BRD | Director/Board Member | 46 | 01/11/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-10 | Other | Director | 100,000 | 0.0039% | ||
| 06-10 | Other | Founder | 100,000 | 0.0039% | ||
| 05-26 | Other | Founder | 100,000 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.68% | +5.41% | +16.25% | +60.99% | 3.9B | |
| -0.17% | +1.61% | +16.42% | +85.22% | 48.73B | |
| +1.04% | -1.02% | +69.47% | +115.88% | 35.82B | |
| -0.13% | -1.29% | -2.60% | +41.58% | 12.2B | |
| -0.71% | +0.89% | +18.28% | +97.87% | 12.11B | |
| -0.76% | +0.38% | +33.16% | +123.08% | 9.11B | |
| -0.86% | +0.37% | +52.61% | -3.54% | 7.09B | |
| +0.75% | -0.82% | +17.49% | +44.79% | 7B | |
| +0.69% | +3.25% | +19.90% | +243.91% | 6.7B | |
| +5.45% | -7.36% | -17.93% | +13.17% | 5.78B | |
| Average | +0.70% | +1.12% | +22.31% | +82.29% | 14.84B | |
| Weighted average by Cap. | +0.36% | +0.65% | +29.43% | +89.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.47B 11.54B 1.29B 1.19B 1.1B 2.08B 140B 2.12B 14.19B 5.57B 69.18B 5.53B 5.41B 238B | 1.67B 13.07B 1.46B 1.34B 1.24B 2.36B 159B 2.4B 16.06B 6.31B 78.3B 6.26B 6.12B 269B |
| Net income | 241M 1.89B 211M 194M 180M 341M 22.98B 346M 2.32B 912M 11.32B 905M 885M 38.92B | 283M 2.22B 247M 228M 211M 400M 26.98B 407M 2.73B 1.07B 13.29B 1.06B 1.04B 45.69B |
| Net Debt | -221M -1.73B -193M -178M -164M -312M -21.04B -317M -2.13B -835M -10.36B -828M -810M -35.62B | -84.71M -664M -74.09M -68.34M -63.12M -120M -8.08B -122M -817M -321M -3.98B -318M -311M -13.68B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | HK$12.09 | +1.68% | 6,915,000 |
| 09/07/26 | HK$11.89 | +2.15% | 10,578,099 |
| 08/07/26 | HK$11.64 | -0.43% | 6,904,000 |
| 07/07/26 | HK$11.69 | -2.83% | 6,589,120 |
| 06/07/26 | HK$12.03 | +4.88% | 15,258,986 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2096 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
